europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

IFF joins EuropaBio: Applying Science and Creativity for a Better World

14/10/2021
PRESS RELEASE

IFF joins EuropaBio: Applying Science and Creativity for a Better World

Brussels, 12 October 2021 – EuropaBio is pleased to announce that IFF has joined as a corporate member.

Founded 1889, IFF is an industry leader in food, beverage, health, biosciences and sensorial experiences, with more than 110 manufacturing facilities, 100 R&D centers, and 45,000 customers across the world. Inspired by nature and distinguished by its world-class bioscience and microbiome capabilities, IFF’s Health & Biosciences (H&B) division is a leading innovation partner for customers across a broad range of consumer products, industrial and agricultural sectors. H&B works closely with customers to enhance products – and their processes – to deliver safer, healthier and more sustainable solutions. As a member of EuropaBio, IFF is strengthening its commitment to responsible innovation and to deliver sustainable benefits from such innovations.

EuropaBio Director-General Dr. Claire Skentelbery commented “IFF defines the shape of biotechnology for the future, cutting across sectors and applications. It really shows us how the world can transition into biomanufacture for sustainable and innovative products and processes. They are a strong addition to the EuropaBio community”.

IFF’s Simon Herriott, President, IFF Health & Biosciences added: “We are delighted to join the EuropaBio community, especially at a time when sustainability has emerged as a primary driver of public policy around the world. IFF is ready to engage as a thought leader and as an innovator of sustainable solutions such as enzymes and biopolymers, to tackle society’s climate change challenges”.

IFF – New Member post

IFF joins EuropaBio


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023


Read more
23/05/2023

EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation


Read more
10/05/2023

#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee


Read more
10/05/2023

Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski


Read more

Important links

  • SwedenBIO joins EuropaBio: helping innovative companies succeed!
  • Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies